bundles
CJC-1295 + IPAMORELIN
Synergistic GH releasing peptide stack
Research Compound
Manufactured under strict quality control protocols with full analytical testing. Certificate of Analysis (COA) available upon request.
The classic synergistic combination of CJC-1295 (GHRH analog) and Ipamorelin (GHRP) provides comprehensive growth hormone axis stimulation. Used extensively in GH axis research.
Compound Specifications
Scientific Documentation
Research Reference
Detailed research information, pharmacological profile, and handling specifications
Mechanism of Action
CJC-1295 with DAC extends the GHRH signal for days via drug affinity complex technology. Ipamorelin selectively stimulates GHS-R1a (ghrelin receptor) without significant cortisol or prolactin release, producing clean GH pulses.
Research Use Only Disclaimer
This product is intended strictly for laboratory and research purposes only. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. By purchasing, you confirm that you are an authorized researcher or institution and that this product will be used solely for legitimate research purposes in compliance with all applicable laws and regulations.
Related Compounds
Other research peptides you may be interested in
TESAMORELIN 10MG
GHRH analog for metabolic and body composition research
$65
IGF-1 LR3
Long-acting IGF-1 analog for growth research
$65
MOTS-C
Mitochondrial peptide for metabolic research
from $40